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Practice guidelines recommend outpatient care for selected patients with non-
massive pulmonary embolism (PE), but fail to specify how these low-risk patients
should be identified. Using data from U.S. patients, we previously derived the
Pulmonary Embolism Severity Index (PESI), a prediction rule that risk stratifies
patients with PE.We sought to validate the PESI in a European patient cohort.We
prospectively validated the PESI in patients with PE diagnosed at six emergency
departments in three European countries. We used baseline data for the rule's 11
prognostic variables to stratify patients into five risk classes (I-V) of increasing
probability of mortality.The outcome was overall mortality at 90 days after
presentation.To assess the accuracy of the PESI to predict mortality, we estimated
the sensitivity, specificity, and predictive values for low- (risk classes I/II) versus
higher-risk patients (risk classes III-V), and the discriminatory power using the area
under the receiver operating characteristic (ROC) curve.Among 357 patients with
PE, overall mortality was 5.9%, ranging from 0% in class I to 17.9% in class V.The
186 (52%) low-risk patients had an overall mortality of 1.1% (95% confidence
interval [CI]: 0.1–3.8%) compared to 11.1% (95% CI: 6.8–16.8%) in the 171 (48%)
higher-risk patients.The PESI had a high sensitivity (91%, 95% CI: 71–97%) and a
negative predictive value (99%, 95% CI: 96–100%) for predicting mortality. The area
under the ROC curve was 0.78 (95% CI: 0.70–0.86). The PESI reliably identifies
patients with PE who are at low risk of death and who are potential candidates for
outpatient care. The PESI may help physicians make more rational decisions about
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